Compounds > peptide elongation factor 2
Page last updated: 2024-08-26

peptide elongation factor 2 and Heart Disease, Ischemic

peptide elongation factor 2 has been researched along with Heart Disease, Ischemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beauloye, C; Bertrand, L; Demeulder, B; Ginion, A; Horman, S; Hue, L; Rider, MH; Vanoverschelde, JL; Viollet, B; Zarrinpashneh, E1
Beauloye, C; Horman, S; Hue, L; Rider, MH; Vanoverschelde, JL; Vertommen, D1

Other Studies

2 other study(ies) available for peptide elongation factor 2 and Heart Disease, Ischemic

ArticleYear
Differential regulation of eEF2 and p70S6K by AMPKalpha2 in heart.
    Biochimica et biophysica acta, 2013, Volume: 1832, Issue:6

    Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinases; Animals; Carrier Proteins; Enzyme Activation; Mice; Mice, Knockout; Muscle Proteins; Myocardial Ischemia; Myocardium; Peptide Elongation Factor 2; Regulatory-Associated Protein of mTOR; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases

2013
Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2.
    The Journal of biological chemistry, 2003, Oct-24, Volume: 278, Issue:43

    Topics: AMP-Activated Protein Kinases; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Elongation Factor 2 Kinase; Heart Function Tests; Hypoxia; In Vitro Techniques; Male; Multienzyme Complexes; Myocardial Ischemia; Myocytes, Cardiac; Oxygen; Peptide Elongation Factor 2; Perfusion; Phosphorylation; Protein Biosynthesis; Protein Kinases; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; TOR Serine-Threonine Kinases

2003